What is harder to find is a provider who treats you as a patient rather than a customer and builds your program around clinical evidence rather than trends
GLP-1 medications are all the rage, improving weight loss, metabolic health, potentially addressing brain-based disorders, the heart, the liver, kidney, all these potential impacts
We get it cost is a real concern
GLP-1 Obesity Medicines Revolutionize Diabetes Market Lower-cost GLP-1 obesity medicines could mark the next major shift in the global diabetes and obesity market
Plant-based foods, on the other hand, reduce the risk of heart disease, stroke, and diabetes
As co-agonists are developed and proposed to have greater glycemic and intestinotrophic effects, further understanding of the endogenous signaling and target cells can only improve tailoring and outcomes